Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs JetBlue Airways Corporation (JBLU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs JetBlue Airways Corporation — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.59 (market cap $12.58B), while JetBlue Airways Corporation trades at $3.85 (market cap $1.48B). The key difference: Halozyme Therapeutics Inc. Common Stock is far larger — about 8.5× JetBlue Airways Corporation's market cap, and Halozyme Therapeutics Inc. Common Stock is trading nearer its 52-week high, JetBlue Airways Corporation nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and JetBlue Airways Corporation for 44 Days on average.
| HALO | JBLU | |
|---|---|---|
Market Cap | $12.58B | $1.48B |
Volume | 2,179,278 | 30,275,693 |
Sector | Health | Industrials |
52-Week High | $115.22 | $6.46 |
52-Week Low | $61.63 | $3.92 |
Typical Hold Time | 1 Days | 44 Days |
Enterprise Value | $14.49B | $8.84B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
JetBlue (JBLU) trades at $3.84, down 3.27% today, reflecting ongoing challenges in the airline sector. The stock shows bearish technical signals with negative moving averages and oscillators. Fundamentally, JBLU reported a net loss of $602 million in 2025 with negative profit margins, though revenue remains stable at $9.06 billion. Recent developments include route expansion to Colombia and the launch of BlueFirst premium seating, while activist investor Carl Icahn recently reduced board representation.
The outlook remains challenging with elevated fuel costs and competitive pressures. While the stock trades below book value (P/B 0.93) and analyst consensus target of $5.89, persistent losses and high debt levels pose significant risks. Institutional buying by Bank of America provides some support, but profitability improvement is essential for sustained recovery.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About JetBlue Airways Corporation
JetBlue Airways Corp is a low-cost airline that offers high-quality service, including assigned seating and in-flight entertainment. It carries over millions of customers with an average of more than 1,000 daily flights and served approximately 99 destinations in the United States, the Caribbean, and Latin America. The company currently operates Airbus A321, Airbus A320, and Embraer E190 aircraft types.
Read more on JBLU →
